As dengue cases continue to rise, the official launch of the E.N.D. Dengue Coalition in the Philippines represents a crucial and timely development. The formation of the coalition marks a significant step in the collective commitment to protect communities and reduce the impact of dengue across the country. Supported by 20 founding organizations, the E.N.D. Dengue Coalition focuses on critical areas such as epidemiology, vector control, clinical management, vaccine development, and advocacy. A unified effort is key to achieving the goal of reducing dengue cases by 50% and eliminating dengue deaths by 2030. The fight continues, and it’s more important than ever that we come together to END dengue. #ENDDengue #DenguePrevention #Philippines #HealthAdvocacy #PublicHealth Lulu Bravo Rose Capeding Philippine Medical Association, Philippine College of Physicians, Philippine Pediatric Society, Inc, Philippine Society for Microbiology and Infectious Diseases, Pediatric Infectious Diseases Society of the Philippines, Council of Professional Health Associations, Philippine Foundation for Vaccination, Vaccine Study Group, Philippine Nurses Association, Inc., Association of Municipal Health Officers of the Philippines, Philippine Alliance of Patient Organizations, Philippine Ambulatory Pediatrics Association, Philippine Red Cross, Philippine Federation of Professional Association, Assocation of Medical Doctors of Asia, philippine academy of family physicians, Philippine Society of Public Health Physicians, Society of Pediatric Critical Care Medicine, Rotary Club of 3080, Asian Medical Students' Association-Philippines (AMSA-Philippines)
Asia Dengue Voice & Action (ADVA) Group
Education Administration Programs
ADVA is a scientific working group dedicated to information and recommendations on dengue vaccine strategies in Asia.
About us
The Asia Dengue Voice & Action Group (ADVA) is a scientific working group dedicated to dengue vaccine advocacy in Asia, with the aim of disseminating information and making recommendations on dengue vaccine introduction strategies in Asia. ADVA aims to identify opportunities to make practical recommendations in dengue-related areas such as improving surveillance and laboratory capacity for dengue disease confirmation with other relevant dengue initiatives, including V2V (vaccine to vaccination) and the Dengue Vaccine Initiative.
- Website
-
https://www.adva.asia/
External link for Asia Dengue Voice & Action (ADVA) Group
- Industry
- Education Administration Programs
- Company size
- 2-10 employees
- Headquarters
- Hong Kong SAR
- Type
- Nonprofit
- Founded
- 2013
- Specialties
- Infectious diseases, Dengue, Vector Control, epidemiology, Vaccine, Diagnotics, Antiviral strategies, Dengue Immunity, and Advocacy
Locations
-
Primary
Get directions
Hong Kong SAR, HK
Employees at Asia Dengue Voice & Action (ADVA) Group
Updates
-
𝟴𝘁𝗵 𝗔𝘀𝗶𝗮 𝗗𝗲𝗻𝗴𝘂𝗲 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱 – Early Bird Registration Now Open! 🌍🦟 Join global scientists, healthcare professionals, policymakers, and public health leaders at the 8th Asia Dengue Summit 2025 to advance strategies in 𝗱𝗲𝗻𝗴𝘂𝗲 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻, 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗽𝗼𝗹𝗶𝗰𝘆. 📅 𝗗𝗮𝘁𝗲: 16 – 17 June 2025 📍 𝗩𝗲𝗻𝘂𝗲: Crowne Plaza Manila Galleria, Philippines Discussions will focus on: ✔ 𝗧𝗵𝗲 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗲𝗽𝗶𝗱𝗲𝗺𝗶𝗼𝗹𝗼𝗴𝘆 𝗼𝗳 𝗱𝗲𝗻𝗴𝘂𝗲 – Country experiences, gains, challenges, and ways forward ✔ 𝗗𝗲𝗻𝗴𝘂𝗲 𝗽𝗮𝘁𝗵𝗼𝗴𝗲𝗻𝗲𝘀𝗶𝘀 & 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 – Best practices in resource-limited settings ✔ 𝗗𝗲𝗻𝗴𝘂𝗲 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 & 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀 ✔ 𝗣𝗼𝗹𝗶𝗰𝘆, 𝗮𝗱𝘃𝗼𝗰𝗮𝗰𝘆, 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 & 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 🚀 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝗮𝗻𝗱 𝘁𝗮𝗸𝗲 𝗮𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲 𝗼𝗳 𝗲𝗮𝗿𝗹𝘆 𝗯𝗶𝗿𝗱 𝗿𝗮𝘁𝗲𝘀! 🔗 Visit www.asiadenguesummit.org for the latest programme updates and event details. 📢 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿, 𝘄𝗲 𝗰𝗮𝗻 𝗺𝗼𝘃𝗲 𝘁𝗼𝘄𝗮𝗿𝗱𝘀 𝘇𝗲𝗿𝗼 𝗱𝗲𝗻𝗴𝘂𝗲 𝗱𝗲𝗮𝘁𝗵𝘀! #ADVA #dengue #zerodenguedeaths #Asia #Collaboration #Innovation #Action
-
-
Day 2 at the APIC-ADVA Summit featured discussions tackling critical gaps in vaccine development, regional security, and equitable immunization. Keynote sessions emphasized the need for ASEAN vaccine security, a life-course approach to immunization, and advancing equitable and sustainable immunization amid global challenges. Panels explored progress in vaccine security, priority populations, and best practices in risk communication and community engagement. The Industry Symposium featured Bavarian Nordic's Mpox Emergency, while the APIC Educational Symposium delved into revolutionizing RSV management. Excited for more impactful conversations on Day 3—stay tuned! #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases
Day 2 Recap: Strengthening Vaccine Collaborations & Communication The day saw thought-provoking conversations on the critical role of cross-country and industry collaboration in closing immunization gaps and a fiery discussion on vaccine risks communication strategies. 💡 Advancing Vaccine Development and Delivery Progress 🔹Dr Sushant Sahastrabuddhe, MD, MPH,MBA emphasized the need to build end-to-end capabilities for successful vaccine delivery. Mapping out gaps across the vaccine manufacturing and supply chain, he called for greater support to strengthen infrastructure—not just in times of crisis, but during peacetime. 🔹This was echoed by the expert panel, featuring Dr.Sunate Chuenkitmongkol, Ms Jennifer Frances dela Rosa, Dr Zhiming (Neal) Xiao, Pandu Harimurti, Dr Basil Rodriques and Youngmi Cho which stressed that public-private partnerships are key to ensuring vaccine security and accessibility. Fronted by voices across intergovernmental organizations, the panel highlighted the need to view vaccine capacity building as a long-term effort, treating it as enhancing national capacity. 🔹Thereafter, Dr.Sunate Chuenkitmongkol provided an important update on the ASEAN Vaccine Security and Self-Reliance (AVSSR) initiative, outlining regional efforts to boost vaccine production, reduce dependency on external supply chains, and enhance cooperation among ASEAN nations. The mission: to achieve sustainable vaccine access and preparedness for future outbreaks. 💡 Tackling Vaccine Risk Communication 🔹 Prof Julie Leask delivered a compelling keynote on the golden rules of vaccine risk communication, highlighting the need to engage the public, communicate with clarity and empathy, and collaborate with trusted sources. 🔹 She then joined a riveting panel discussion featuring Prof Lulu Bravo and Dr Leong Hoe Nam that explored communication strategies to combat vaccine hesitancy and build public trust. The panel took on tough questions from the audience, including the delicate balance between countering misinformation and preserving open dialogue on vaccine concerns. It is promised to be yet another day of invigorating discussions that explore and address pressing challenges in today’s infectious diseases landscape at last day of APIC-ADVA Summit Get a sneak peek of the program here: https://lnkd.in/eBf_k4qq #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases
-
-
-
-
-
+4
-
-
What a lively and engaging Day 1 at the APIC-ADVA Summit 2025, filled with insightful discussions on advancing global health and pandemic preparedness! The summit kicked off with keynote plenaries on the future of global health and leadership in a post-pandemic world, followed by roundtable perspectives from Director-Generals of Health in the region. Industry symposiums focused on the integration of immunization in Southeast Asia's dengue prevention and advancing RSV as an immunization-preventable disease for infants. Keynote speakers highlighted innovative strategies for equitable access to vaccines, regional approaches to global health security, and the transformative role of digital technology in addressing climate and health challenges. Stay tuned for Day 2 summary, where the conversation continues, and we dive deeper into innovative solutions for tackling global health challenges! #APICSummit #Immunization #Vaccination #HealthEquity #InfectiousDiseases
💡Day 1 Recap: APIC-ADVA Summit 2025 💡 Day 1 of the APIC-ADVA Summit set the stage for critical conversations on the future of global health and pandemic preparedness. Minister for Foreign Affairs, Dr Vivian Balakrishnan, opened the summit with a compelling keynote, emphasizing three key priorities: ✔ Strengthening multilateralism and vaccine equity ✔ Restoring trust in science and evidence-based collaboration ✔ Building domestic resilience With global health crises inevitable, he urged nations to act now to ensure swift and effective responses in the future. 📰 Pulitzer Prize-winning journalist Laurie Garrett followed with an urgent call to address vaccine inequity and unequal access to health tools. Warning that we are at a global inflection point, she underscored the importance of not relying on a single country’s public health funding. 💉 Prof. David L. Heymann reflected on past successes in securing vaccine equity for polio, contrasting them with the challenges faced during COVID-19. His thought-provoking question: What national interests are high-income countries willing to set aside for the greater global good? 🌍 A high-level roundtable featuring Director-Generals of Health Sir Ashley Bloomfield KNZM CMInstD, Prof Kenneth Mak, Hisham Abdullah and Dr Enrique A. Tayag underscored a crucial takeaway: pandemic preparedness must shift from a public health issue to a national security priority. The time to prepare is now—before the next crisis strikes. 📢 Stay tuned for insights from Days 2 and 3! #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases
-
-
-
-
-
+5
-
-
We are at the Asia Pacific Immunization Coalition (APIC)-Asia Dengue Voice & Action (ADVA) Group Summit! At today’s symposium on “From Trials to Implementation: Advancing the Integration of Immunization in Southeast Asia’s Holistic Dengue Prevention Approach”, sponsored by Takeda, experts from across Southeast Asia explored how immunization can be integrated into holistic dengue prevention efforts. 🔹 Dr. dr H Jaya Mualimin shared East Kalimantan’s experience in integrating dengue vaccination with vector control, emphasizing the need for stakeholder coordination, public education, and government support. 🔹 Dr. Nakorn Premsri highlighted Thailand’s commitment to dengue management through public-private partnerships, vaccine R&D, and data-driven decision-making—aiming for zero dengue deaths. He also outlined ASEAN Vaccine Security and Self-Reliance (AVSSR) goals and Thailand’s role in advancing the initiative. 🔹 Dr. Nikki K. emphasized that we are in a new era of dengue control, where next-generation vaccines and advanced vector control complement traditional methods. She underscored the importance of whole-of-society engagement and data-driven implementation to scale immunization efforts. Moderated by Azrul Mohd Khalib, the panel discussion reinforced that immunization is not a replacement but a vital addition to holistic dengue prevention. The APIC-ADVA Summit runs until 13 Feb, bringing together global public health leaders to tackle urgent challenges and shape the future of immunization and health equity. Join us! #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases #PublicHealth
-
-
Pivotal conversations on immunization are coming your way! Next week, the Asia Pacific Immunization Coalition (APIC)-Asia Dengue Voice & Action (ADVA) Group Summit 2025 will bring together leading health authorities from around the world to tackle pressing challenges and shape the future of vaccination. From policy to innovation, collaboration will be key to advancing the future of immunization. View the full day 2 programme here: https://lnkd.in/eBf_k4qq Don't miss out, sign up today! https://lnkd.in/gRpsxD6c https://lnkd.in/gPAsEVaQ #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases
Get ready for an impactful day featuring a stellar line-up of global public health leaders from The World Bank, UNICEF, Gavi, the Vaccine Alliance and Clinton Health Access Initiative, Inc. Building on the critical discussions from Day 1, Day 2 dives deeper into strategies to close immunization gaps worldwide. This conversation is especially urgent as we confront mounting threats from mpox, dengue, influenza, and RSV. 💡 What to Expect ✔ Roundtable Perspectives: Closing gaps: Progress on Vaccine Security and Cooperation in the Region • Dr.Sunate Chuenkitmongkol, Deputy Director, Scientific Affairs, National Vaccine Institute, Thailand • Pandu Harimurti, Senior Health Specialist, World Bank Jakarta • Basil Rodriques, Regional Health Adviser, UNICEF East Asia & Pacific Regional Office • Youngmi Cho, Head of Global Affairs and Communications, International Vaccine Institute ✔ Industry Symposium by Bavarian Nordic Mpox Emergency: Global Epidemiology and the Role of Vaccination with MVA-BN as a Critical Countermeasure • Kay Choong See, Adjunct Associate Professor, Yong Loo Lin School of Medicine, National University of Singapore who will share about bridging global insights to the APAC region • Ralph Torgler, PhD, Global Medical Affairs, Bavarian Nordic Berna GmbH, Switzerland who will share the advancements in the MVA-BN vaccine • This panel will be moderated by David L. Heymann, renowned epidemiologist and former WHO Assistant Director for Health Security ✔ Keynote Plenary: • Anamaria Bejar, Director Public Policy Engagement, Gavi the Vaccine Alliance, who will discuss the critical role of public policy in driving vaccine equity • Sushant Sahastrabuddhe, MD, MPH,MBA, Associate Director General, Innovation, Initiatives & Enterprise Development, International Vaccine Institute, who will highlight the transformative potential of innovation in vaccine development and deployment 📜 View the full Day 2 program: https://lnkd.in/eBf_k4qq 🖊 Secure your spot today: https://lnkd.in/gRpsxD6c We look forward to seeing you there! #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases
-
-
Just one week to go until the 2nd Asia Pacific Immunization Coalition (APIC)-Asia Dengue Voice & Action (ADVA) Group Summit on 11-13 February 2025! Join global public health leaders for high-level discussions on policy, innovation, and expert insights into tackling global health threats. View the full Day 1 program: https://lnkd.in/eBf_k4qq Register now and be part of the conversation: https://lnkd.in/gRpsxD6c #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases https://lnkd.in/gzdDRx97
📅 See you soon!: 11–13 February 2025 Join us for three impactful days of discussions at the 2nd APIC-ADVA Summit, where global public health leaders converge to tackle crucial challenges and shape the future of immunization and health equity. Key topics to be discussed include the most pressing diseases of our time such as mpox, dengue, influenza and RSV. 🎤 Day 1 Highlights We’re honored to have Singapore’s Minister for Foreign Affairs, Dr. Vivian Balakrishnan, as our Guest-of-Honor. He will inaugurate the summit with a keynote address on the critical need for pandemic preparedness in a turbulent world marked by overlapping crises and the weakening of multilateral organizations. It will also highlight Singapore’s commitment to strengthening healthcare resilience, advancing regional cooperation, and building a more sustainable and equitable system to respond to future global health emergencies. 🌟 Featured Speakers & Sessions ✔ Roundtable Perspectives: Advancing Pandemic Preparedness: Policy and Innovation Lessons for the Future •Ashley Bloomfield, Former Director-General of Health, New Zealand •Kenneth Mak, Director-General of Health, Ministry of Health, Singapore •Hisham Abdullah, Former Director-General of Health, Malaysia •Enrique Tayag, Former Undersecretary, Department of Health, Philippines ✔ Keynote Plenary: •Laurie Garrett, Pulitzer Prize-winning journalist and author of The Coming Plague and Betrayal of Trust, will deliver an incisive address on the evolving landscape of global public health. •David L. Heymann, renowned epidemiologist and former WHO Assistant Director for Health Security, will share his expert insights on tackling infectious disease threats. •Dr Sylvie Briand, Director of the Pandemic and Epidemic Diseases Department at the World Health Organization, to share her key takeaways from Day 1 of the Summit from a WHO perspective. And this is just a teaser! In addition to the esteemed line-up above, hear also from representatives from World Health Organization, The World Bank, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative, Inc., International Vaccine Institute (IVI), UK Health Security Agency, and other prominent organizations. It’s a Summit not to be missed. 📜 View the full Day 1 program: https://lnkd.in/eBf_k4qq 🖊 Register now: https://lnkd.in/gRpsxD6c Let’s advance public health together. Don’t miss out! #APICSummit #Vaccination #Immunization #HealthEquity #InfectiousDiseases
-
-
Join global health leaders in Singapore from 11-13 February 2025 at the 2nd Asia Pacific Immunization Coalition (APIC)-Asia Dengue Voice & Action (ADVA) Group Asia Pacific Summit on Infectious Diseases and Immunization! Themed "In the Era of Polycrises", this year’s summit dives into today’s most pressing health challenges, from pandemic preparedness and vaccine risk communication to the transformative potential of implementation science research. Learn from more than 40 world-renowned speakers, including top policymakers, researchers, and global health advocates, and engage in dynamic discussions on public health policies, government-industry collaborations, and strategies to build resilience! Secure your spot today by registering now! https://lnkd.in/gRpsxD6c #APICSummit2025 ##Immunization ##GlobalHealth ##InfectiousDiseases
-
As 2024 comes to a close, officially reported #dengue cases are set to surpass all previous records. There have been over 12 million cases worldwide this year—a 24-fold increase since 2000—making dengue the world’s fastest-growing mosquito-borne disease, now exacerbated by #climatechange. A year ago, at #COP28 in Dubai, with the world’s attention firmly on the accelerating impact of climate on health, nearly 30 global stakeholders came together to begin a transformative journey towards helping to reduce the burden of dengue. Now, we celebrate the anniversary of this meeting and the conception of the Collective Action on Dengue initiative, a unique collaboration that brings together experts from academia, industry, foundations, NGOs and more, dedicated to tackling the rising impact of dengue. A group of organizations, including Asia Dengue Voice & Action (ADVA) Group, Duke-NUS Medical School, FIND, International Society For Neglected Tropical Diseases (ISNTD), International Society for Urban Health (ISUH), Malaria No More, MSD, Sabin Vaccine Institute, Takeda, Vista Health Pte Ltd and World Mosquito Program (WMP) are working together to advance this initiative, laser focused on the Collective Action on Dengue's three strategic pillars—Urbanization, Innovation and Advocacy—to engage communities and contribute to building resilience against the spread of dengue. Keep an eye out for updates on the strides we're making towards tackling this public health threat— more exciting developments to come!
-
-
We are excited to announce that Asia Dengue Voice & Action (ADVA) Group will host a symposium on Dengue Fever tomorrow at 12pm during the 11th Asian Congress of Pediatric Infectious Diseases (ACPID 2024)! This insightful session, moderated by the esteemed Prof EunHwa Choi will feature leading dengue experts: Prof. Usa Thisyakorn: Roadmap to Zero Dengue Death Prof. Zulkifli Ismail: Community-Driven Approaches to Combat Dengue Prof. Maria Rosario Capeding: Vaccine Evolution and Advancements Don’t miss this opportunity to hear from top experts and contribute to the global fight against dengue! Register here: https://lnkd.in/gJVfhAbk #ADVA #ACPID2024 #DengueAwareness #GlobalHealth
-